The sustained Transcatheter Aortic Valve Replacement (TAVR) Market growth is rooted in the procedural shift from surgery to minimally invasive intervention for aortic valve replacement. The primary engine of this growth is the increasing acceptance of TAVR for patients across all surgical risk spectrums, particularly in the vast, previously untapped low-risk category, following favorable...